ACE2 Protein and mRNA Expression in Tissue
Expression levels were determined using the HPA (https://www.proteinatlas.org). Tissues that express ACE2 were broken down into five categories based off of the amount of ACE2 mRNA expression:
- (1, highest expression, score range: 122-10) small intestine, colon, duodenum, kidney, testis, gallbladder and heart muscle
- (2, medium high expression, score range: 5-1) adipose tissue, thyroid gland, epididymis, ductus deferens, breast, pancreas, rectum, ovary, esophagus, liver, seminal vesicle, salivary gland and placenta
- (3, medium low expression, score range: 0.9-0.5) vagina, lung, appendix, skeletal muscle, fallopian tube, lymph node, tongue, stomach and prostate
- (4, low expression, score range: 0.4-0.1) remaining tissues
- (5, no expression, score range: 0) parathyroid gland, bone marrow, monocytes, B-cells, NK-cells, dendritic cells and total peripheral blood mononuclear cell

0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Organs and Organ Systems Affected by COVID-19
Tissue ACE2 Expression Levels as Related to COVID-19 Symptoms
Effects of the ACE2 receptors on organ tissues of COVID-19 patients
ACE2 Protein and mRNA Expression in Tissue
Hypotheses Regarding ACE2 Expression in Tissue and COVID-19
ACE2 Expression in Adipose Tissue May Contribute to COVID-19 Morbidity and Mortality in Obese Patients
Graph of the Expression of ACE2 in Various Tissues
ACE2 Expression in Human Airway Epithelial Tissue
Cancer Tissue Expression of ACE2
ACE2 Protein and mRNA Expression in Tissue
Expression of ACE2 in Tissue and COVID-19
ACE2 Expression in the Human Brain